Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Mazurek

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Synapse (New York, N.Y.)|November 5, 1997
Role of glutamate receptor subtypes in the differential release of somatostatin, neuropeptide Y, and substance P in primary serum-free cultures of striatal neuronsS Garside, M F Mazurek
Lancet (London, England)|July 20, 1991
Serum iron and neuroleptic malignant syndromeP I Rosebush, M F Mazurek
Experimental Neurology|March 1, 1996
Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's diseaseJ C Furtado, M F Mazurek
Neurology|July 1, 1987
Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortexM F Beal, M F Mazurek
Neurology|May 1, 1991
Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortexM F Mazurek, M F Beal
Journal of Clinical Psychopharmacology|August 1, 1996
Catatonia after benzodiazepine withdrawalP I Rosebush, M F Mazurek
Neurology|March 17, 1999
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidoneP I Rosebush, M F Mazurek
The American Journal of Psychiatry|May 1, 1996
Circadian pattern of acute, neuroleptic-induced dystonic reactionsM F Mazurek, P I Rosebush
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1991
MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's diseaseJ C Furtado, M F Mazurek
Neuroscience|February 1, 1997
The ontogeny of NADPH-diaphorase neurons in serum-free striatal cultures parallels in vivo developmentS Garside, J Woulfe, M F Mazurek
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Synapse (New York, N.Y.)|November 5, 1997
Role of glutamate receptor subtypes in the differential release of somatostatin, neuropeptide Y, and substance P in primary serum-free cultures of striatal neuronsS Garside, M F Mazurek
Lancet (London, England)|July 20, 1991
Serum iron and neuroleptic malignant syndromeP I Rosebush, M F Mazurek
Experimental Neurology|March 1, 1996
Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's diseaseJ C Furtado, M F Mazurek
Neurology|July 1, 1987
Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortexM F Beal, M F Mazurek
Neurology|May 1, 1991
Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortexM F Mazurek, M F Beal
Journal of Clinical Psychopharmacology|August 1, 1996
Catatonia after benzodiazepine withdrawalP I Rosebush, M F Mazurek
Neurology|March 17, 1999
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidoneP I Rosebush, M F Mazurek
The American Journal of Psychiatry|May 1, 1996
Circadian pattern of acute, neuroleptic-induced dystonic reactionsM F Mazurek, P I Rosebush
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1991
MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's diseaseJ C Furtado, M F Mazurek
Neuroscience|February 1, 1997
The ontogeny of NADPH-diaphorase neurons in serum-free striatal cultures parallels in vivo developmentS Garside, J Woulfe, M F Mazurek
Pageof 6